je.st
news
Barclays Increases Hologic, Inc. (HOLX) Price Target to $42.00
2016-01-10 09:08:11| Biotech - Topix.net
The firm currently has an "equal weight" rating on the stock. Barclays' price objective indicates a potential upside of 14.91% from the stock's previous close.
Tags: price
target
increases
barclays
Category:Biotechnology and Pharmaceuticals